SHEET /m/orforglipron · PubChem CID 137319706 · CAS 2212020-52-3 · REV 2026.07
marquee
Orforglipron
from sourceC48H48F2N10O5 · 883 g/mol
Foundayo
What is Orforglipron?
A GLP-1 medicine sold as Foundayo, approved by the FDA on 1 April 2026 for chronic weight management. Unlike semaglutide it is a small molecule, not a peptide. from source
CategoryPrescription medicine
LeaderboardsBiggest
Fig. 1 · 2D structure RDKit
SMILES
C[C@H]1C[C@]1(C2=NOC(=O)N2)N3C4=C(C=C(C=C4)[C@H]…153 charactersWhere you'll find it
Dispensed on prescription, not sold on a shelf. See the rest of the prescription medicine group.
Sources & methodology
- PubChem CID
- 137319706
- Wikidata
- Q120491908
- Structure
- PubChem → RDKit
- Data refreshed